These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 36163187)
1. Novel lipid-coated mesoporous silica nanoparticles loaded with thymoquinone formulation to increase its bioavailability in the brain and organs of Wistar rats. Fahmy HM; Ahmed MM; Mohamed AS; Shams-Eldin E; Abd El-Daim TM; El-Feky AS; Mustafa AB; Abd Alrahman MW; Mohammed FF; Fathy MM BMC Pharmacol Toxicol; 2022 Sep; 23(1):71. PubMed ID: 36163187 [TBL] [Abstract][Full Text] [Related]
2. Targeting of Thymoquinone-loaded mesoporous silica nanoparticles to different brain areas: In vivo study. Fahmy HM; Fathy MM; Abd-Elbadia RA; Elshemey WM Life Sci; 2019 Apr; 222():94-102. PubMed ID: 30826496 [TBL] [Abstract][Full Text] [Related]
3. Biotinylated-lipid bilayer coated mesoporous silica nanoparticles for improving the bioavailability and anti-leukaemia activity of Tanshinone IIA. Li Z; Zhang Y; Zhang K; Wu Z; Feng N Artif Cells Nanomed Biotechnol; 2018; 46(sup1):578-587. PubMed ID: 29374971 [TBL] [Abstract][Full Text] [Related]
4. Targeted anticancer potential against glioma cells of thymoquinone delivered by mesoporous silica core-shell nanoformulations with pH-dependent release. Shahein SA; Aboul-Enein AM; Higazy IM; Abou-Elella F; Lojkowski W; Ahmed ER; Mousa SA; AbouAitah K Int J Nanomedicine; 2019; 14():5503-5526. PubMed ID: 31410001 [TBL] [Abstract][Full Text] [Related]
5. Lipid bilayer-coated mesoporous silica nanoparticles carrying bovine hemoglobin towards an erythrocyte mimic. Tu J; Bussmann J; Du G; Gao Y; Bouwstra JA; Kros A Int J Pharm; 2018 May; 543(1-2):169-178. PubMed ID: 29567198 [TBL] [Abstract][Full Text] [Related]
6. Folic acid modified lipid-bilayer coated mesoporous silica nanoparticles co-loading paclitaxel and tanshinone IIA for the treatment of acute promyelocytic leukemia. Li Z; Zhang Y; Zhu C; Guo T; Xia Q; Hou X; Liu W; Feng N Int J Pharm; 2020 Aug; 586():119576. PubMed ID: 32603839 [TBL] [Abstract][Full Text] [Related]
7. Thermo-responsive mesoporous silica/lipid bilayer hybrid nanoparticles for doxorubicin on-demand delivery and reduced premature release. Zhang Q; Chen X; Shi H; Dong G; Zhou M; Wang T; Xin H Colloids Surf B Biointerfaces; 2017 Dec; 160():527-534. PubMed ID: 29024917 [TBL] [Abstract][Full Text] [Related]
8. Mesoporous Silica Nanoparticle-Coated Microneedle Arrays for Intradermal Antigen Delivery. Tu J; Du G; Reza Nejadnik M; Mönkäre J; van der Maaden K; Bomans PHH; Sommerdijk NAJM; Slütter B; Jiskoot W; Bouwstra JA; Kros A Pharm Res; 2017 Aug; 34(8):1693-1706. PubMed ID: 28536970 [TBL] [Abstract][Full Text] [Related]
9. Thymoquinone loaded mesoporous silica nanoparticles retard cell invasion and enhance in vitro cytotoxicity due to ROS mediated apoptosis in HeLa and MCF-7 cell lines. Goel S; Mishra P Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109881. PubMed ID: 31499940 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and Biodistribution of Thymoquinone-loaded Nanostructured Lipid Carrier After Oral and Intravenous Administration into Rats. Zakarial Ansar FH; Latifah SY; Wan Kamal WHB; Khong KC; Ng Y; Foong JN; Gopalsamy B; Ng WK; How CW; Ong YS; Abdullah R; Aziz MY Int J Nanomedicine; 2020; 15():7703-7717. PubMed ID: 33116496 [TBL] [Abstract][Full Text] [Related]
11. Chemically reducible lipid bilayer coated mesoporous silica nanoparticles demonstrating controlled release and HeLa and normal mouse liver cell biocompatibility and cellular internalization. Roggers RA; Lin VS; Trewyn BG Mol Pharm; 2012 Sep; 9(9):2770-7. PubMed ID: 22738645 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of the therapeutic effect of mesoporous silica nanoparticles loaded with Gallic acid on reserpine-induced depression in Wistar rats. Fahmy HM; Mohamed ER; Hussein AA; Khadrawy YA; Ahmed NA BMC Pharmacol Toxicol; 2022 Jun; 23(1):40. PubMed ID: 35705968 [TBL] [Abstract][Full Text] [Related]
13. Improving Solubility and Bioavailability of Breviscapine with Mesoporous Silica Nanoparticles Prepared Using Ultrasound-Assisted Solution-Enhanced Dispersion by Supercritical Fluids Method. Yang G; Li Z; Wu F; Chen M; Wang R; Zhu H; Li Q; Yuan Y Int J Nanomedicine; 2020; 15():1661-1675. PubMed ID: 32210559 [TBL] [Abstract][Full Text] [Related]
14. Construction of calcium carbonate-liposome dual-film coated mesoporous silica as a delayed drug release system for antitumor therapy. Wang Y; Zhao K; Xie L; Li K; Zhang W; Xi Z; Wang X; Xia M; Xu L Colloids Surf B Biointerfaces; 2022 Apr; 212():112357. PubMed ID: 35101825 [TBL] [Abstract][Full Text] [Related]
15. Coated and Hollow Microneedle-Mediated Intradermal Immunization in Mice with Diphtheria Toxoid Loaded Mesoporous Silica Nanoparticles. Du G; Woythe L; van der Maaden K; Leone M; Romeijn S; Kros A; Kersten G; Jiskoot W; Bouwstra JA Pharm Res; 2018 Aug; 35(10):189. PubMed ID: 30105542 [TBL] [Abstract][Full Text] [Related]
16. Novel scheme for rapid synthesis of hollow mesoporous silica nanoparticles (HMSNs) and their application as an efficient delivery carrier for oral bioavailability improvement of poorly water-soluble BCS type II drugs. Li T; Geng T; Md A; Banerjee P; Wang B Colloids Surf B Biointerfaces; 2019 Apr; 176():185-193. PubMed ID: 30616109 [TBL] [Abstract][Full Text] [Related]
18. Development and biological evaluation of protective effect of kidney targeted N-acetylated chitosan nanoparticles containing thymoquinone for the treatment of DNA damage in cyclophosphamide-induced haemorrhagic cystitis. Prajapati C; Agrawal YO; Agnihotri VV; Mahajan UB; Patil KR; Patil DD; Patil CR Int J Biol Macromol; 2022 Aug; 214():391-401. PubMed ID: 35714868 [TBL] [Abstract][Full Text] [Related]
19. The properties of mesoporous silica nanoparticles functionalized with different PEG-chain length via the disulfide bond linker and drug release in glutathione medium. Xie Z; Gong H; Liu M; Zhu H; Sun H J Biomater Sci Polym Ed; 2016; 27(1):55-68. PubMed ID: 26540096 [TBL] [Abstract][Full Text] [Related]
20. Curcumin loaded mesoporous silica nanoparticles: assessment of bioavailability and cardioprotective effect. Yadav YC; Pattnaik S; Swain K Drug Dev Ind Pharm; 2019 Dec; 45(12):1889-1895. PubMed ID: 31549866 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]